SOLENO THERAPEUTICS INC

SLNO

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001873522-26-000007
Filing date: Mar 4, 2026
Earliest execution date: Mar 2, 2026
Reporting Owners: Fulk Jennifer (CFO)

Summary

Type

Neutral

Net shares

+39,200

% of shares

100.00%

Amount (USD)

$0

Insider confidence score

90.0 out of 100

Positive

  • Massive buy (≥10% of shares)

Negative

  • Minimal buy amount (<$10K)

Stock transactions

Transaction 1

Security

Common Stock

Action

Grant

Date

2026-03-02

Code

A

Net shares

+39,200.0

Acquired/Disposed

Acquired

Shares Owned Before

0.0

Shares Owned After

39,200.0

Derivative Transactions

Transaction 1

Security

Employee stock option (right to buy)

Action

Exercise

Date

2026-03-02

Code

M

Net shares

+67,660.0

Acquired/Disposed

Acquired

Shares Owned Before

0.0

Shares Owned After

67,660.0

Filing's footnotes

1. These securities are restricted stock units (&quot;RSUs&quot;). Each RSU represents a contingent right to receive one share of Common Stock. 25% of RSUs shall vest on each of March 2, 2027, March 2, 2028, March 2, 2029 and March 2, 2030, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date.

2. One-fourth of the shares subject to the option shall vest on March 2, 2027 and one forty-eighth of the shares subject to the option shall vest each month thereafter on the same day of the month, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.